Capsule and Sprinkle Formulations of Lubiprostone Are Not Biologically Similar in Patients with Functional Constipation

INTRODUCTION: Lubiprostone capsules are approved for managing three different chronic constipation conditions. A “sprinkle” formulation may facilitate use in individuals with difficulty swallowing capsules. Our objective was to evaluate the bioequivalence, pharmacokinetics (PK), and bioavailability...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Adv Ther
Autors principals: Adams, Atoya, Barish, Charles, Chen, Angel, Dennis, Patrick, Krause, Richard, Lichtlen, Peter, Losch-Beridon, Taryn, Mareya, Shadreck, Schneider, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: Springer Healthcare 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8190023/
https://ncbi.nlm.nih.gov/pubmed/33834354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01707-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars